Anagenics Limited (ASX:AN1)
Australia
· Delayed Price · Currency is AUD 0.0080
0.00 (0.00%)
Aug 29, 2024, 3:30 PM AEST
Anagenics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | 7.26 | 10.8 | 9.11 | 6.95 | 5.82 | 7.34 | Upgrade
|
| Revenue | 7.26 | 10.8 | 9.11 | 6.95 | 5.82 | 7.34 | Upgrade
|
| Revenue Growth (YoY) | -28.84% | 18.54% | 31.21% | 19.41% | -20.81% | -0.61% | Upgrade
|
| Cost of Revenue | 4.45 | 6.44 | 4.7 | 3.15 | 2.11 | 2.5 | Upgrade
|
| Gross Profit | 2.81 | 4.36 | 4.41 | 3.8 | 3.7 | 4.85 | Upgrade
|
| Selling, General & Admin | 5.68 | 7.19 | 6.08 | 6.82 | 6.45 | 8.07 | Upgrade
|
| Research & Development | 0.01 | 0.01 | 0.02 | 0.03 | 0.12 | 0.4 | Upgrade
|
| Other Operating Expenses | 0.14 | 0.42 | -0.38 | -0.76 | 0.39 | 0.56 | Upgrade
|
| Operating Expenses | 6.22 | 8.21 | 6.16 | 6.51 | 6.96 | 9.03 | Upgrade
|
| Operating Income | -3.41 | -3.85 | -1.75 | -2.71 | -3.26 | -4.18 | Upgrade
|
| Interest Expense | -0.05 | -0.07 | -0.03 | -0.04 | -0.05 | -0.07 | Upgrade
|
| Interest & Investment Income | - | - | - | 0.02 | 0.02 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.23 | - | 0.04 | 1 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -3.23 | -3.92 | -1.73 | -1.74 | -3.29 | -4.23 | Upgrade
|
| Impairment of Goodwill | -2.74 | -2.74 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.16 | Upgrade
|
| Asset Writedown | -0.63 | -0.63 | - | - | -0.64 | - | Upgrade
|
| Other Unusual Items | 0.3 | - | - | 0.09 | 0.17 | 0.13 | Upgrade
|
| Pretax Income | -6.38 | -7.28 | -1.73 | -1.64 | -3.76 | -4.27 | Upgrade
|
| Income Tax Expense | - | - | 0.01 | 0 | 0.05 | 0.09 | Upgrade
|
| Earnings From Continuing Operations | -6.38 | -7.28 | -1.74 | -1.64 | -3.8 | -4.36 | Upgrade
|
| Earnings From Discontinued Operations | 0.37 | -0.21 | -0.93 | -2.01 | 0.42 | -0.55 | Upgrade
|
| Net Income to Company | -6.01 | -7.49 | -2.67 | -3.65 | -3.39 | -4.91 | Upgrade
|
| Net Income | -6.01 | -7.49 | -2.67 | -3.65 | -3.39 | -4.91 | Upgrade
|
| Net Income to Common | -6.01 | -7.49 | -2.67 | -3.65 | -3.39 | -4.91 | Upgrade
|
| Shares Outstanding (Basic) | 351 | 399 | 266 | 209 | 141 | 97 | Upgrade
|
| Shares Outstanding (Diluted) | 351 | 399 | 266 | 209 | 141 | 97 | Upgrade
|
| Shares Change (YoY) | 3.48% | 50.02% | 27.01% | 48.30% | 45.04% | 28.55% | Upgrade
|
| EPS (Basic) | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 | -0.05 | Upgrade
|
| Free Cash Flow | -2.06 | -1.84 | -1.8 | -2.56 | -4.14 | -4.01 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | -0.04 | Upgrade
|
| Gross Margin | 38.68% | 40.37% | 48.41% | 54.66% | 63.68% | 66.01% | Upgrade
|
| Operating Margin | -47.07% | -35.64% | -19.16% | -39.03% | -56.00% | -56.89% | Upgrade
|
| Profit Margin | -82.78% | -69.36% | -29.27% | -52.53% | -58.23% | -66.81% | Upgrade
|
| Free Cash Flow Margin | -28.35% | -17.00% | -19.80% | -36.88% | -71.12% | -54.64% | Upgrade
|
| EBITDA | -3 | -3.23 | -1.39 | -2.62 | -3.1 | -3.94 | Upgrade
|
| EBITDA Margin | -41.30% | -29.94% | -15.22% | -37.74% | -53.27% | -53.67% | Upgrade
|
| D&A For EBITDA | 0.42 | 0.62 | 0.36 | 0.09 | 0.16 | 0.24 | Upgrade
|
| EBIT | -3.41 | -3.85 | -1.75 | -2.71 | -3.26 | -4.18 | Upgrade
|
| EBIT Margin | -47.07% | -35.64% | -19.16% | -39.03% | -56.00% | -56.89% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.